Pathogenesis and treatment of type 2 diabetic nephropathy: lessons from the spontaneous KK/Ta mouse model

Yasuhiko Tomino1, Mitsuo Tanimoto, Toshihide Shike

  • 1Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan. yasu@med.juntendo.ac.jp

Current Diabetes Reviews
|January 29, 2008
PubMed

Insights

The KK/Ta mouse model offers a valuable tool for studying diabetic nephropathy, closely mimicking human early-stage kidney disease. This model aids research into genetic factors and treatments for type 2 diabetes complications.

Area of Science:

  • Nephrology
  • Endocrinology
  • Genetics

Background:

  • Diabetic nephropathy is a leading cause of end-stage renal failure in diabetes patients.
  • Disease progression is influenced by genetic, hyperglycemic, hypertensive, and dyslipidemic factors.
  • Human diabetic nephropathy is complex, necessitating reliable animal models for mechanistic studies.

Purpose of the Study:

  • To evaluate the KK/Ta mouse as a model for human type 2 diabetes and early diabetic nephropathy.
  • To review genetic susceptibility factors using genome-wide linkage analysis and DD-PCR/Northern blot.
  • To examine the efficacy of treatments like ARBs and TZDs in this model.

Main Methods:

  • Comparative analysis of KK/Ta mice and BALB/c mice for metabolic and renal parameters.
  • Genome-wide linkage analysis to identify genetic susceptibility loci.
  • Differential display polymerase chain reaction (DD-PCR) and Northern blot analysis for gene expression.
  • Administration of angiotensin type 1 (AT1) receptor blockers (ARBs) and thiazolidinediones (TZDs) to assess treatment effects.

Main Results:

  • KK/Ta mice exhibit distinct genetic backgrounds, body weight, blood glucose, impaired glucose tolerance, albuminuria, and triglyceride levels compared to BALB/c mice.
  • Renal lesions in KK/Ta mice closely resemble early human diabetic nephropathy.
  • The KK/Ta model is suitable for investigating genetic factors and therapeutic interventions in diabetic nephropathy.

Conclusions:

  • The KK/Ta mouse is a relevant model for studying type 2 diabetes and early diabetic nephropathy.
  • This model facilitates the investigation of genetic susceptibility and the evaluation of potential treatments for diabetic kidney disease.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...